The study debunks the logic of anti-choice efforts to force doctors to use the FDA’s outdated standards.
The decision leaves in place an earlier ruling allowing a 2011 law restricting medication abortions to go into effect.
The Roberts Court declined to take up a request by attorneys for the State of Arizona to overturn a federal appeals court decision calling the case for medication abortion restrictions “non-existent.”
In two separate orders, the state’s highest court blocked new hospital admitting privileges requirements and restrictions on medication abortions from taking effect while trials challenging their legality proceed.
Attorneys from the Center for Reproductive Rights filed an emergency appeal with the Oklahoma Supreme Court asking them to blocking a ruling Wednesday that allowed new restrictions on medication abortions to take effect.
The order gives attorneys for the state time to file a request with the U.S. Supreme Court to review an appeals court order blocking limitations on RU-486.
The study is the first academic evaluation of the impact of HB 2 to be released since the law passed last year.
A panel of judges is considering overturning a lower court’s ruling that the state’s 20-week abortion ban is unconstitutional.
The new southeast Dallas facility will be one of eight legal abortion providers left in Texas after September 1.
In a strongly worded opinion, the U.S. Court of Appeals for the Ninth Circuit said attorneys for Arizona failed to offer any evidence supporting the need for restrictions on medication abortions.